Literature DB >> 26064458

Right ventricular remodeling in idiopathic and scleroderma-associated pulmonary arterial hypertension: two distinct phenotypes.

Benjamin W Kelemen1, Stephen C Mathai1, Ryan J Tedford2, Rachel L Damico3, Cecilia Corona-Villalobos4, Todd M Kolb3, Neal F Chaisson3, Traci Housten Harris3, Stefan L Zimmerman4, Ihab R Kamel4, David A Kass2, Paul M Hassoun3.   

Abstract

Patients with scleroderma (SSc)-associated pulmonary arterial hypertension (PAH) have worse survival than patients with idiopathic PAH (IPAH). We hypothesized that the right ventricle (RV) adapts differently in SSc-PAH versus IPAH. We used cardiac magnetic resonance imaging (cMRI) and hemodynamic characteristics to assess the relationship between RV morphology and RV load in patients with SSc-PAH and IPAH. In 53 patients with PAH (35 with SSc-PAH and 18 with IPAH) diagnosed by right heart catheterization (RHC), we examined cMRIs obtained within 48 hours of RHC and compared RV morphology between groups. Regression analysis was used to assess the association between diagnosis (IPAH vs. SSc-PAH) and RV measurements after adjusting for age, sex, race, body mass index (BMI), left ventricular (LV) mass, and RV load. There were no significant differences in unadjusted comparisons of cMRI measurements between the two groups. Univariable regression showed RV mass index (RVMI) was linearly associated with measures of RV load in both the overall cohort and within each group. Multivariable linear regression models revealed a significant interaction between disease type and RVMI adjusting for pulmonary vascular resistance (PVR), age, sex, race, BMI, and LV mass. This model showed a decreased slope in the relationship between RVMI and PVR in the SSc-PAH group compared with the IPAH group. RVMI varies linearly with measures of RV load. After adjusting for multiple potential confounders, patients with SSc-PAH demonstrated significantly less RV hypertrophy with increasing PVR than patients with IPAH. This difference in adaptive hypertrophy may in part explain previously observed decreased contractility and poorer survival in SSc-PAH.

Entities:  

Keywords:  cardiac magnetic resonance imaging; pulmonary arterial hypertension; right ventricle; scleroderma

Year:  2015        PMID: 26064458      PMCID: PMC4449244          DOI: 10.1086/680356

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  31 in total

1.  Clinical differences between idiopathic and scleroderma-related pulmonary hypertension.

Authors:  Micah R Fisher; Stephen C Mathai; Hunter C Champion; Reda E Girgis; Traci Housten-Harris; Laura Hummers; Jerry A Krishnan; Fredrick Wigley; Paul M Hassoun
Journal:  Arthritis Rheum       Date:  2006-09

2.  Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension.

Authors:  Serge A van Wolferen; Johannes T Marcus; Anco Boonstra; Koen M J Marques; Jean G F Bronzwaer; Marieke D Spreeuwenberg; Pieter E Postmus; Anton Vonk-Noordegraaf
Journal:  Eur Heart J       Date:  2007-01-22       Impact factor: 29.983

3.  Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.

Authors:  Eric Hachulla; Virginie Gressin; Loïc Guillevin; Patrick Carpentier; Elisabeth Diot; Jean Sibilia; André Kahan; Jean Cabane; Camille Francès; David Launay; Luc Mouthon; Yannick Allanore; Kiet Phong Tiev; Pierre Clerson; Pascal de Groote; Marc Humbert
Journal:  Arthritis Rheum       Date:  2005-12

4.  Long-term effects of epoprostenol on the pulmonary vasculature in idiopathic pulmonary arterial hypertension.

Authors:  Stuart Rich; Jennifer Pogoriler; Aliya N Husain; Peter T Toth; Mardi Gomberg-Maitland; Stephen L Archer
Journal:  Chest       Date:  2010-11       Impact factor: 9.410

5.  Tricuspid annular displacement predicts survival in pulmonary hypertension.

Authors:  Paul R Forfia; Micah R Fisher; Stephen C Mathai; Traci Housten-Harris; Anna R Hemnes; Barry A Borlaug; Elzbieta Chamera; Mary C Corretti; Hunter C Champion; Theodore P Abraham; Reda E Girgis; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2006-08-03       Impact factor: 21.405

6.  Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.

Authors:  Mariëlle C van de Veerdonk; Taco Kind; J Tim Marcus; Gert-Jan Mauritz; Martijn W Heymans; Harm-Jan Bogaard; Anco Boonstra; Koen M J Marques; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  J Am Coll Cardiol       Date:  2011-12-06       Impact factor: 24.094

7.  Pulmonary capillary wedge pressure augments right ventricular pulsatile loading.

Authors:  Ryan J Tedford; Paul M Hassoun; Stephen C Mathai; Reda E Girgis; Stuart D Russell; David R Thiemann; Oscar H Cingolani; James O Mudd; Barry A Borlaug; Margaret M Redfield; David J Lederer; David A Kass
Journal:  Circulation       Date:  2011-11-30       Impact factor: 29.690

Review 8.  Controversies in ventricular remodelling.

Authors:  Lionel H Opie; Patrick J Commerford; Bernard J Gersh; Marc A Pfeffer
Journal:  Lancet       Date:  2006-01-28       Impact factor: 79.321

9.  Echocardiographic Assessment of Right Ventricular Volume and Function.

Authors:  Leng Jiang; Robert A. Levine; Arthur E. Weyman
Journal:  Echocardiography       Date:  1997-03       Impact factor: 1.724

10.  Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach.

Authors:  D Mukerjee; D St George; B Coleiro; C Knight; C P Denton; J Davar; C M Black; J G Coghlan
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

View more
  7 in total

1.  Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension.

Authors:  Steven Hsu; Brian A Houston; Emmanouil Tampakakis; Anita C Bacher; Parker S Rhodes; Stephen C Mathai; Rachel L Damico; Todd M Kolb; Laura K Hummers; Ami A Shah; Zsuzsanna McMahan; Celia P Corona-Villalobos; Stefan L Zimmerman; Fredrick M Wigley; Paul M Hassoun; David A Kass; Ryan J Tedford
Journal:  Circulation       Date:  2016-05-11       Impact factor: 29.690

Review 2.  Progress in Understanding, Diagnosing, and Managing Cardiac Complications of Systemic Sclerosis.

Authors:  George Hung; Valentina Mercurio; Steven Hsu; Stephen C Mathai; Ami A Shah; Monica Mukherjee
Journal:  Curr Rheumatol Rep       Date:  2019-12-07       Impact factor: 4.592

3.  Ventricular mass as a prognostic imaging biomarker in incident pulmonary arterial hypertension.

Authors:  Catherine E Simpson; Rachel L Damico; Todd M Kolb; Stephen C Mathai; Rubina M Khair; Takahiro Sato; Khalil Bourji; Ryan J Tedford; Stefan L Zimmerman; Paul M Hassoun
Journal:  Eur Respir J       Date:  2019-04-04       Impact factor: 16.671

4.  Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.

Authors:  Rahul G Argula; Abhijit Karwa; Abigail Lauer; David Gregg; Richard M Silver; Carol Feghali-Bostwick; Lynn M Schanpp; Kim Egbert; Bruce W Usher; Viswanathan Ramakrishnan; Paul M Hassoun; Charlie Strange
Journal:  Ann Am Thorac Soc       Date:  2017-05

Review 5.  Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment.

Authors:  Umberto Attanasio; Alessandra Cuomo; Flora Pirozzi; Stefania Loffredo; Pasquale Abete; Mario Petretta; Gianni Marone; Domenico Bonaduce; Amato De Paulis; Francesca Wanda Rossi; Carlo Gabriele Tocchetti; Valentina Mercurio
Journal:  Int J Mol Sci       Date:  2020-06-22       Impact factor: 5.923

Review 6.  Right Ventricle Remodeling and Function in Scleroderma Patients.

Authors:  Roxana Cucuruzac; Iolanda Muntean; Imre Benedek; Andras Mester; Nora Rat; Adriana Mitre; Monica Chitu; Theodora Benedek
Journal:  Biomed Res Int       Date:  2018-03-20       Impact factor: 3.411

7.  Non-invasive right ventricular load adaptability indices in patients with scleroderma-associated pulmonary arterial hypertension.

Authors:  Sarah French; Myriam Amsallem; Nadia Ouazani; Shufeng Li; Kristina Kudelko; Roham T Zamanian; Francois Haddad; Lorinda Chung
Journal:  Pulm Circ       Date:  2018-06-25       Impact factor: 3.017

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.